Dihydrofolate Reductase Antikörper
-
- Target Alle Dihydrofolate Reductase (DHFR) Antikörper anzeigen
- Dihydrofolate Reductase (DHFR)
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Dihydrofolate Reductase Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Verwendungszweck
- DHFR Rabbit mAb
- Kreuzreaktivität
- Human, Maus, Ratte
- Produktmerkmale
- Monoclonal Antibodies
- Aufreinigung
- Affinity purification
- Immunogen
- A synthesized peptide derived from human DHFR
- Isotyp
- IgG
- Top Product
- Discover our top product DHFR Primärantikörper
-
-
- Applikationshinweise
- WB,1:500 - 1:2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,0.05 % BSA,50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- Dihydrofolate Reductase (DHFR)
- Andere Bezeichnung
- DHFR (DHFR Produkte)
- Hintergrund
- Dihydrofolate reductase converts dihydrofolate into tetrahydrofolate, a methyl group shuttle required for the de novo synthesis of purines, thymidylic acid, and certain amino acids. While the functional dihydrofolate reductase gene has been mapped to chromosome 5, multiple intronless processed pseudogenes or dihydrofolate reductase-like genes have been identified on separate chromosomes. Dihydrofolate reductase deficiency has been linked to megaloblastic anemia. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2014],DHFRP1, DYR,Amino acid metabolism,Cancer,Cell Biology & Developmental Biology,Endocrine & Metabolism,Nucleotide metabolism,Signal Transduction,DHFR
- Molekulargewicht
- 21kDa
- Gen-ID
- 1719
- UniProt
- P00374
- Pathways
- Mitotic G1-G1/S Phases
-